. 2016 Jul 8;30(10):1371–1377. doi: 10.1038/eye.2016.142

Table 1. Baseline parameters and treatment outcome after subthreshold micropulse laser and photodynamic therapy.

	Treatment response	Complete resolution of SRF	CRT (μm) baseline Mean±SD	CRT (μm) after therapy Mean±SD	P-value	Decrease in CRT (μm) Mean±SD	Increase in BCVA of 1 or more lines	BCVA (LogMAR) baseline Mean±SD	BCVA (LogMAR) after therapy	P-value	Increase in BCVA (LogMAR) Mean±SD
All patients (n=100)	67 of 100 (67%)	27 of 100 (27%)	418±121	311±94**	P<0.001** Wilcoxon's signed-rank test	-106±136	50 of 100 (50%)	0.37±0.24	0.31±0.25**	P=0.001** Wilcoxon's signed-rank test	−0.059±0.168
SML (n=42)	33 of 42 (79%)*	15 of 42 (36%)	445±153	297±95**	P<0.001** Wilcoxon's signed-rank test	−148±163*	23 of 42 (55%)	0.39±0.24	0.31±0.27**	P=0.003** Wilcoxon signed-rank test	−0.081±0.167
PDT (n=58)	34 of 58 (59%)*	12 of 58 (21%)	398±88	322±93**	P<0.001** Wilcoxon's signed-rank test	−76±104*	27 of 58 (47%)	0.35±0.24	0.31±0.24	P=0.077 Wilcoxon's signed-rank test	−0.043±0.169
P-value*	P=0.036* χ² test	P=0.095 χ² test	P=0.242 Mann–Whitney U-test			P=0.041* Mann–Whitney U-Test	P=0.418 χ² test	P=0.360 Mann–Whitney U-test			P=0.349 Mann–Whitney U-test

**Statistically significant difference before and after therapy.

*Statistically significant difference between the SML and the PDT group.